Shares of AbbVie Inc. (NYSE: ABBV) rose over 1.03% in early trading session on Friday as patients in the United States will be able to purchase cheaper versions of AbbVie Inc.'s (ABBV) blockbuster arthritis drug Humira, though the cost savings are expected to be modest. Amjevita, the first biosimilar version of AbbVie's 20-year-old drug, was launched on Tuesday by rival drugmaker Amgen Inc, with two pricing tiers. One option is to apply a 5% discount to Humira's monthly price of $6,922. The other is roughly half the price but may not be widely available. The majorities of patients’ co-insurance costs are set as a percentage of the...

GoPro, Inc. (NASDAQ: GPRO) jumps down over 10.14% to $5.81 in early trading session on Friday as the firm announced financial results for its fourth quarter. "In 2022, GoPro achieved GAAP profitability in a very challenging macroeconomic environment. We generated EBITDA of $95 million, or 9% of revenue. Additionally, we grew subscribers to 2.25 million, bringing our subscription and service revenue to an annual run rate of $100 million with 70-80% gross margin," said Nicholas Woodman, GoPro's founder and CEO. GoPro's CFO and COO Brian McGee said that GoPro ended the year with solid balance sheet metrics and $367 million in cash after repaying $125 million in...

Shares of AbbVie Inc. (NYSE: ABBV) rose over 1.03% in early trading session on Friday as patients in the United States will be able...